Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients

This publication has 15 references indexed in Scilit:

• Excision Margins in High-Risk Malignant Melanoma
  New England Journal of Medicine, 2004
• Impact of vaccinations and infectious diseases on the risk of melanoma—evaluation of an EORTC case–control study
  European Journal Of Cancer, 2003
• Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients
  British Journal of Dermatology, 2003
• Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study
  Journal of Investigative Dermatology, 2002
• Cohort studies: marching towards outcomes
  The Lancet, 2002
• Environmental Echoes
  Science Progress, 2001
• Infections and melanoma risk
  Melanoma Research, 1999
• Development of allergen-specific T-cell memory in atopic and normal children
  The Lancet, 1999
• Review Environmental factors and primary T‐cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution
  Pediatric Allergy and Immunology, 1995
• Common infections in the history of cancer patients and controls
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1991